Exhibit 99.1
     
(ALLION HEALTHCARE LOGO)
  Allion Healthcare, Inc.
1660 Walt Whitman Road, Suite 105
Melville, NY 11747
Tel: (631) 547-6520
 
   
 
Allion Healthcare Reports Second quarter 2008 Results
  Net sales for the quarter increased 39% to a record $86.4 million
  Net income increased 200% to $2.9 million
  Earnings per diluted share up 83% to $0.11
MELVILLE, NY — August 7, 2008 —
Allion Healthcare (NASDAQ: ALLI) today announced financial results for the three months ended June 30, 2008, which include its recent expansion into the Specialty Infusion market. As a result of the April 4, 2008 acquisition of Biomed America, Inc. (“Biomed”), the Company now operates its business in two segments: Specialty HIV, which is the Company’s legacy specialty pharmacy and disease management services focused on HIV/AIDS patients, and Specialty Infusion, which is the Company’s recently acquired Biomed business of specialized biopharmaceutical medications and services to chronically ill patients. Results for the second quarter reflect the acquisition of Biomed effective April 4, 2008.
Summary of Results
Consolidated net sales for the second quarter of 2008 increased 39% to $86.4 million, compared to $62.3 million for the second quarter of 2007. Same store sales from the Company’s Specialty HIV segment increased 10% to $68.7 million principally resulting from patient growth in its California market. The number of Specialty HIV prescriptions filled increased 7% over the same period in 2007. The Biomed acquisition added $17.7 million in Specialty Infusion revenues during the second quarter of 2008. Approximately 93% of the Specialty Infusion sales were from Hemophilia patients receiving Blood Clotting Factor and patients with Auto Immune Disorders/Neuropathies receiving IVIG.
Gross profit was $17.1 million and $8.9 million for the three months ended June 30, 2008 and 2007, respectively, and represents 19.8% and 14.3% of net sales, respectively. The increase in gross profit as a percentage of revenues is primarily attributable to the relatively higher gross margins of our Specialty Infusion business compared to our Specialty HIV business. The Company’s gross margin from the Specialty HIV segment remained approximately at historical levels.
Selling, general and administrative expenses increased to $9.8 million, or 11.3% of net sales, during the second quarter of 2008, compared to $6.5 million, or 10.5% of net sales, during the second quarter of 2007. The increase was primarily due to the acquisition of the Specialty Infusion segment. The Company does not expect to realize significant cost efficiencies as a result of the Biomed acquisition.
The Company reported net income for the period of $2.9 million, a three fold increase when compared to net income of $973,000 for the second quarter of 2007.

 


The following information was filed by Allion Healthcare Inc on Thursday, August 7, 2008 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Allion Healthcare Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Allion Healthcare Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account